Solid Biosciences (SLDB) Capital Expenditures (2017 - 2026)
Solid Biosciences (SLDB) recorded Capital Expenditures of $150,000 in Q2 2026, down 60.2% from $377,000 a year earlier and down 9.1% from the prior quarter.
Powered by 
Analysis
Solid Biosciences (SLDB) Capital Expenditures (2017 - 2026) Analysis & Trends
On a TTM basis, Solid Biosciences' Capital Expenditures came in at $965,000 as of Jun 30, 2026, up 33.7% year-over-year; for FY2025, it was $1.15 million, up 76.3% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $654,000 in FY2024 (-56.8%), $1.52 million in FY2023 (-49.8%), $3.02 million in FY2022 (+135.4%) and $1.28 million in FY2021 (+42.5%).
- Quarterly Capital Expenditures has ranged from $15,000 in Q3 2024 to $1.14 million in Q2 2022 over the past five years.
- On a year-over-year basis, Capital Expenditures rose in five of the last eight quarters, with growth averaging 82.7%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 466.7% in Q3 2025, against a decline of 96.1% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $165,000 (Q1 2026), $565,000 (Q4 2025) and $85,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.02 Bn | 1,100.60 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 613.16 Bn | 531.69 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.74 Bn | 476.85 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.66 Bn | 261.65 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.30 Bn | 234.99 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.04 Bn | 191.44 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.96 Bn | 165.16 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 169.89 Bn | 116.53 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Solid Biosciences | 926.07 Mn | -256.28 Mn | - | 150,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 150,000.00 |
| Mar 31, 2026 | 165,000.00 |
| Dec 31, 2025 | 565,000.00 |
| Sep 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 377,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Dec 31, 2024 | 204,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 286,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | 383,000.00 |
| Jun 30, 2023 | 536,000.00 |
| Mar 31, 2023 | 506,000.00 |
| Dec 31, 2022 | 856,000.00 |
| Sep 30, 2022 | 839,000.00 |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 184,000.00 |
| Dec 31, 2021 | 660,000.00 |
| Sep 30, 2021 | 237,000.00 |
API Access
Solid Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();